PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 21.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $78,000 | +9.9% | 40,000 | 0.0% | 0.02% | +7.1% |
| Q1 2015 | $71,000 | -4.1% | 40,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $74,000 | -23.7% | 40,000 | 0.0% | 0.01% | -30.0% |
| Q3 2014 | $97,000 | -33.6% | 40,000 | 0.0% | 0.02% | -31.0% |
| Q2 2014 | $146,000 | -20.2% | 40,000 | 0.0% | 0.03% | -23.7% |
| Q1 2014 | $183,000 | – | 40,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,178,440 | $5,338,000 | 5.83% |
| GREAT POINT PARTNERS LLC | 399,007 | $1,808,000 | 1.25% |
| Camber Capital Management LP | 1,790,000 | $8,109,000 | 0.85% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,041,078 | $4,716,000 | 0.43% |
| FEDERATED HERMES, INC. | 10,427,472 | $47,237,000 | 0.18% |
| SILVERBACK ASSET MANAGEMENT LLC | 272,200 | $1,233,000 | 0.10% |
| Catalyst Capital Advisors LLC | 30,000 | $136,000 | 0.07% |
| OBERWEIS ASSET MANAGEMENT INC/ | 54,200 | $246,000 | 0.07% |
| Baillie Gifford | 5,548,351 | $25,134,000 | 0.06% |
| Fore Research & Management, LP | 200,000 | $906,000 | 0.06% |